Skip to main content

Vericel Corp

VCEL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000887359

In the last 90 days, Vericel Corp insiders filed 0 open-market purchases and 7 sales; 320 institutions reported holding it in 13F filings for Q2 2026, worth $2.47B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Vericel Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
7 filings
6 insiders, $2.48M in total
Insiders trading
6
Net value
−$2.48M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Vericel Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Vericel Corp
NameTitleLast reported holdingLast filingFilings, past year
McLaughlin Kevin FDirector18,300Aug 14, 20265
Halpin MichaelChief Operating Officer16,394Aug 5, 20268
Siegal JonathanPrincipal Accounting Officer1,078Jul 31, 20266
Hopper Jonathan MarkChief Medical Officer75,753Jun 30, 20266
Flynn Sean C.Chief Legal Officer1,647Jun 30, 20265
Mara Joseph Anthony JrChief Financial Officer16,009Jun 30, 20264
Wotton Paul KDirector18,802May 13, 20263
Zerbe Robert L MDDirector32,995May 1, 20261
Rubino Alan LDirector64,194May 1, 20262
Hagen HeidiDirector35,050May 1, 20262
Wright LisaDirector15,851May 1, 20261
Colangelo DominickPresident and CEO312,446Feb 26, 20262
Mahoney KarenChief Human Resources Officer1,854Dec 12, 20251
Gilman Steven CDirector11,000Oct 18, 20240

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 14, 2026 (view filing)4:05 PM ETAug 122 daysMcLaughlin Kevin FDirectorSSale−7.00K$44.53−$311.7K−27.7%18.3K after10b5-1
Aug 5, 2026 (view filing)4:05 PM ETAug 32 daysHalpin MichaelChief Operating OfficerSSale−10.0K$46.84−$468.4K−37.9%16.4K after10b5-1
Jul 31, 2026 (view filing)4:05 PM ETJul 301 daySiegal JonathanPrincipal Accounting OfficerSSale−4.50K$48.90−$220.1K−80.7%1.08K after3 lots10b5-1
Jun 30, 2026 (view filing)Jun 264 daysSiegal JonathanPrincipal Accounting OfficerSSale−2.73K$44.90−$122.7K−75.5%886 after2 lots10b5-1
Jun 30, 2026 (view filing)Jun 264 daysMara Joseph Anthony JrChief Financial OfficerSSale−5.00K$44.75−$223.8K−23.8%16.0K after10b5-1
Jun 30, 2026 (view filing)Jun 264 daysHopper Jonathan MarkChief Medical OfficerSSale−10.0K$45.00−$450.0K−11.7%75.8K after2 lots10b5-1
Jun 30, 2026 (view filing)Jun 264 daysFlynn Sean C.Chief Legal OfficerSSale−15.0K$45.64−$684.6K−90.1%1.65K after10b5-1
Jun 22, 2026 (view filing)Jun 184 daysHalpin MichaelChief Operating OfficerSSale−10.0K$40.24−$402.4K−38.1%16.2K after10b5-1
Jun 22, 2026 (view filing)Jun 184 daysFlynn Sean C.Chief Legal OfficerSSale−15.0K$40.21−$603.1K−90.1%1.65K after10b5-1
Jun 4, 2026 (view filing)Jun 22 daysHopper Jonathan MarkChief Medical OfficerSSale−4.38K$35.00−$153.1K−5.5%75.8K after10b5-1
May 15, 2026 (view filing)May 132 daysMcLaughlin Kevin FDirectorSSale−7.00K$32.83−$229.8K−27.7%18.3K after2 lots10b5-1
May 13, 2026 (view filing)May 112 daysWotton Paul KDirectorSSale−10.0K$32.74−$327.4K−34.7%18.8K after2 lots
May 8, 2026 (view filing)May 71 dayMara Joseph Anthony JrChief Financial OfficerSSale−5.00K$40.50−$202.5K−19.2%21.0K after10b5-1
May 8, 2026 (view filing)May 6-72 daysSiegal JonathanPrincipal Accounting OfficerSSale−4.86K$38.73−$188.0K−81.3%1.12K after2 lots10b5-1
Apr 6, 2026 (view filing)Apr 24 daysHopper Jonathan MarkChief Medical OfficerSSale−3.47K$35.00−$121.5K−4.4%75.6K after10b5-1
Mar 25, 2026 (view filing)Mar 232 daysHagen HeidiDirectorSSale−15.0K$32.41−$486.1K−32.0%31.9K after10b5-1
Mar 4, 2026 (view filing)Mar 22 daysFlynn Sean C.Chief Legal OfficerSSale−21.4K$35.18−$753.5K−94.4%1.26K after2 lots10b5-1
Mar 4, 2026 (view filing)Mar 22 daysHalpin MichaelChief Operating OfficerSSale−10.3K$35.30−$363.8K−39.1%16.1K after10b5-1
Feb 13, 2026 (view filing)Feb 112 daysMcLaughlin Kevin FDirectorSSale−7.00K$34.66−$242.6K−31.7%15.1K after10b5-1
Jan 9, 2026 (view filing)Jan 72 daysHalpin MichaelChief Operating OfficerSSale−10.0K$40.48−$404.8K−38.3%16.1K after10b5-1
Dec 4, 2025 (view filing)Dec 22 daysHopper Jonathan MarkChief Medical OfficerSSale−1.65K$39.14−$64.7K−2.4%66.6K after10b5-1
Dec 4, 2025 (view filing)Dec 2-32 daysWotton Paul KDirectorSSale−5.00K$37.90−$189.5K−16.3%25.6K after2 lots
Nov 13, 2025 (view filing)Nov 112 daysHalpin MichaelChief Operating OfficerSSale−2.64K$40.41−$106.8K−14.2%15.9K after10b5-1
Nov 12, 2025 (view filing)Nov 102 daysMcLaughlin Kevin FDirectorSSale−7.00K$38.59−$270.1K−31.7%15.1K after10b5-1
Nov 10, 2025 (view filing)Nov 64 daysHalpin MichaelChief Operating OfficerSSale−7.36K$40.47−$297.8K−31.6%15.9K after10b5-1
Sep 3, 2025 (view filing)Sep 21 dayHopper Jonathan MarkChief Medical OfficerSSale−10.0K$35.77−$357.7K−13.1%66.4K after10b5-1
Aug 8, 2025 (view filing)Aug 62 daysMcLaughlin Kevin FDirectorSSale−7.00K$35.92−$251.4K−31.7%15.1K after10b5-1
Jun 4, 2025 (view filing)Jun 22 daysHopper Jonathan MarkChief Medical OfficerSSale−10.0K$40.09−$400.9K−13.1%66.2K after10b5-1
May 16, 2025 (view filing)May 14-152 daysColangelo DominickPresident and CEOSSale−28.1K$41.89−$1.18M−9.7%260.4K after2 lots10b5-1
May 9, 2025 (view filing)May 72 daysMcLaughlin Kevin FDirectorSSale−7.00K$39.98−$279.9K−31.7%15.1K after10b5-1
Apr 11, 2025 (view filing)Apr 9-102 daysColangelo DominickPresident and CEOSSale−49.7K$41.50−$2.06M−16.0%260.4K after2 lots10b5-1
Mar 14, 2025 (view filing)Mar 12-132 daysColangelo DominickPresident and CEOSSale−53.2K$46.04−$2.45M−17.0%260.0K after2 lots10b5-1
Mar 5, 2025 (view filing)Mar 32 daysHalpin MichaelChief Operating OfficerSSale−10.0K$49.52−$495.2K−39.2%15.5K after10b5-1
Mar 5, 2025 (view filing)Mar 32 daysHagen HeidiDirectorSSale−9.00K$49.53−$445.8K−23.9%28.6K after10b5-1
Mar 5, 2025 (view filing)Mar 32 daysMara Joseph Anthony JrChief Financial OfficerSSale−9.00K$49.53−$445.8K−39.2%14.0K after10b5-1
Mar 5, 2025 (view filing)Mar 32 daysHopper Jonathan MarkChief Medical OfficerSSale−10.0K$49.53−$495.3K−13.1%66.1K after10b5-1
Feb 26, 2025 (view filing)Feb 251 dayFlynn Sean C.Chief Legal OfficerSSale−1.67K$52.07−$86.9K−68.8%756 after10b5-1
Feb 26, 2025 (view filing)Feb 251 daySiegal JonathanPrincipal Accounting OfficerSSale−1.14K$52.07−$59.2K−48.5%1.21K after10b5-1
Feb 24, 2025 (view filing)Feb 204 daysFlynn Sean C.Chief Legal OfficerSSale−3.83K$57.32−$219.8K−83.5%756 after10b5-1
Feb 20, 2025 (view filing)Feb 191 daySiegal JonathanPrincipal Accounting OfficerSSale−1.71K$56.72−$97.0K−58.6%1.21K after10b5-1
Feb 14, 2025 (view filing)Feb 122 daysMcLaughlin Kevin FDirectorSSale−7.00K$55.46−$388.3K−37.0%11.9K after2 lots10b5-1
Feb 7, 2025 (view filing)Feb 52 daysZerbe Robert L MDDirectorSSale−2.50K$62.50−$156.3K−8.6%26.6K after10b5-1
Feb 7, 2025 (view filing)Feb 52 daysSiegal JonathanPrincipal Accounting OfficerSSale−1.09K$61.99−$67.7K−47.5%1.21K after10b5-1
Jan 30, 2025 (view filing)Jan 282 daysSiegal JonathanPrincipal Accounting OfficerSSale−3.91K$61.99−$242.3K−76.4%1.21K after10b5-1
Dec 5, 2024 (view filing)Dec 41 dayWotton Paul KDirectorSSale−2.60K$58.72−$152.7K−8.7%27.4K after
Dec 3, 2024 (view filing)Dec 21 dayHopper Jonathan MarkChief Medical OfficerSSale−10.0K$58.72−$587.2K−14.6%58.4K after10b5-1
Nov 25, 2024 (view filing)Nov 223 daysZerbe Robert L MDDirectorSSale−2.50K$60.00−$150.0K−8.6%26.6K after10b5-1
Nov 15, 2024 (view filing)Nov 132 daysMcLaughlin Kevin FDirectorSSale−7.00K$55.54−$388.8K−37.0%11.9K after10b5-1
Nov 15, 2024 (view filing)Nov 13-142 daysColangelo DominickPresident and CEOSSale−35.0K$54.75−$1.92M−13.7%220.9K after2 lots10b5-1
Nov 13, 2024 (view filing)Nov 11-122 daysZerbe Robert L MDDirectorSSale−5.00K$56.25−$281.3K−15.8%26.6K after2 lots10b5-1